Related Experiment Video

Updated: Feb 27, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma

Lan Chen1, Yaxuan Cao1, Dongyun Rong1

  • 1Department of Dermatology, The Affiliated Hospital of Guiyang Medical University, Yunyan, Guiyang, Guizhou 550004, P.R. China.

Oncology Reports
|June 29, 2017
PubMed

Insights

MicroRNA 605 (miR-605) is downregulated in melanoma, suppressing tumor growth by targeting the INPP4B gene. This finding highlights miR-605 as a potential therapeutic target for melanoma treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are critical regulators in cancer development, including melanoma.
  • Previous studies suggest miR-605 involvement in carcinogenesis, but its role in melanoma is unclear.

Purpose of the Study:

  • To investigate the expression levels of miR-605 in melanoma.
  • To elucidate the functional role of miR-605 in melanoma progression.
  • To identify the molecular targets and pathways regulated by miR-605 in melanoma.

Main Methods:

  • Quantitative real-time PCR to assess miR-605 expression in melanoma cell lines and tissues.
  • In vitro and in vivo assays to evaluate the effect of miR-605 on melanoma cell growth.
  • Bioinformatics analysis and luciferase reporter assays to identify and validate miR-605 targets.
  • Western blotting to confirm protein level changes and pathway activation.

Main Results:

  • miR-605 was significantly downregulated in melanoma cell lines and clinical specimens.
  • Overexpression of miR-605 inhibited melanoma cell proliferation and tumor growth in vitro and in vivo.
  • The INPP4B gene was identified as a direct target of miR-605.
  • miR-605 suppressed melanoma cell growth by inhibiting INPP4B, which in turn regulated SGK3 activation.

Conclusions:

  • miR-605 acts as a tumor suppressor in melanoma.
  • The miR-605/INPP4B/SGK3 axis is a key pathway in melanoma progression.
  • miR-605 represents a promising therapeutic target for melanoma intervention.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

456

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K